143 Episodio

  1. Immunotherapy rechallenge in NSCLC

    Pubblicato: 03/03/2022
  2. ESO’s career development programme

    Pubblicato: 24/02/2022
  3. Summary/Review - Reporting Guidelines - CONSORT

    Pubblicato: 17/02/2022
  4. Summary/Review: Long-term results of SNB after NCT for primary cN1/2 breast who convert to cN0

    Pubblicato: 10/02/2022
  5. Summary/Review: Pathology after neoadjuvant treatment for breast cancer – How to assess residual disease.

    Pubblicato: 03/02/2022
  6. Intraoperative breast ultrasound

    Pubblicato: 27/01/2022
  7. Summary/Review - Reporting Guidelines - PRISMA 2020

    Pubblicato: 20/01/2022
  8. Summary/Review - The use of Artificial Intelligence in the Oncology field. Addressing all the hype and skepticism.

    Pubblicato: 13/01/2022
  9. Advanced Gastric Cancer

    Pubblicato: 09/12/2021
  10. PARP inhibitors for the treatment of ovarian cancer

    Pubblicato: 02/12/2021
  11. The role of clinician-scientists in modern oncology

    Pubblicato: 25/11/2021
  12. Pharmacologic interactions with new drugs

    Pubblicato: 18/11/2021
  13. Positive Resection Margins in Colon Cancer

    Pubblicato: 11/11/2021
  14. Immunotherapy in Lung Cancer

    Pubblicato: 04/11/2021
  15. Low HR positive breast cancer

    Pubblicato: 28/10/2021
  16. Possibilities of tackling side effects of cancer therapies

    Pubblicato: 21/10/2021
  17. Fertility preservation in young cancer patients

    Pubblicato: 14/10/2021
  18. CDK4/6i in HR+HER2- breast cancer

    Pubblicato: 07/10/2021
  19. Treatment selection in castration-resistant prostate cancer

    Pubblicato: 30/09/2021
  20. Questions and Controversies in Localized Head and Neck Cancer

    Pubblicato: 23/09/2021

6 / 8

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

Visit the podcast's native language site